Lord, Abbett & Co. LLC Pliant Therapeutics, Inc. Transaction History

Lord, Abbett & Co. LLC

$30.7 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Oct 07, 2024	SELL	$18.12 - $30.56 $18.7 Million - $31.5 Million	-1,030,347 Reduced 69.33%	455,823 $8.26 Million
Q2 2023 Aug 14, 2023	SELL	$18.12 - $30.56 $18.7 Million - $31.5 Million	-1,030,347 Reduced 69.33%	455,823 $8.26 Million
Q1 2023 Oct 07, 2024	BUY	$18.73 - $36.26 $18.5 Million - $35.7 Million	985,382 Added 196.77%	1,486,170 $39.5 Million
Q1 2023 May 12, 2023	BUY	$18.73 - $36.26 $18.5 Million - $35.7 Million	985,382 Added 196.77%	1,486,170 $39.5 Million
Q4 2022 Oct 07, 2024	BUY	$17.0 - $25.43 $8.51 Million - $12.7 Million	500,788 New	500,788 $9.68 Million
Q4 2022 Feb 10, 2023	BUY	$17.0 - $25.43 $21,335 - $31,914	1,255 Added 0.25%	500,788 $9.68 Million
Q3 2022 Nov 14, 2022	BUY	$7.67 - $24.23 $1.39 Million - $4.38 Million	180,774 Added 56.71%	499,533 $10.4 Million
Q2 2022 Aug 12, 2022	BUY	$4.11 - $8.75 $89,289 - $190,093	21,725 Added 7.31%	318,759 $2.55 Million
Q1 2022 May 13, 2022	BUY	$7.01 - $14.1 $36,592 - $73,602	5,220 Added 1.79%	297,034 $2.08 Million
Q4 2021 Feb 11, 2022	SELL	$12.27 - $18.26 $34,883 - $51,913	-2,843 Reduced 0.96%	291,814 $3.94 Million
Q3 2021 Nov 09, 2021	SELL	$16.48 - $28.98 $64,865 - $114,065	-3,936 Reduced 1.32%	294,657 $4.97 Million
Q2 2021 Aug 11, 2021	SELL	$28.05 - $37.69 $799,453 - $1.07 Million	-28,501 Reduced 8.71%	298,593 $8.7 Million
Q1 2021 May 11, 2021	BUY	$24.52 - $40.23 $3.38 Million - $5.54 Million	137,690 Added 72.7%	327,094 $12.9 Million
Q4 2020 Feb 09, 2021	SELL	$19.89 - $32.99 $85,566 - $141,922	-4,302 Reduced 2.22%	189,404 $4.3 Million
Q3 2020 Nov 12, 2020	BUY	$21.54 - $29.53 $4.17 Million - $5.72 Million	193,706 New	193,706 $4.39 Million

Others Institutions Holding PLRX

# of Institutions

168

Shares Held

63.2M

Call Options Held

245K

Put Options Held

373K

Deep Track Capital, LP Greenwich, CT

5.97M
Shares

$73.6 Million
2.47% of portfolio
Black Rock Inc. New York, NY

4.97M
Shares

$61.3 Million
0.0% of portfolio
Price T Rowe Associates Inc Baltimore, MD

4.83M
Shares

$59.6 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

3.53M
Shares

$43.4 Million
0.0% of portfolio
Redmile Group, LLC San Francisco, CA

3.2M
Shares

$39.4 Million
2.34% of portfolio

View Full List

About PLIANT THERAPEUTICS, INC.

Ticker PLRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,682,000
Market Cap $600M
Description
Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...

More about PLRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lord, Abbett & Co. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lord, Abbett & Co. LLC with notifications on news.

Account